Dilution of Shareholder Value Through the Exercise of Stock Options
First written in FY2021. 9 of 14 entries say "Materialised", first in FY2023-Q1. Latest entry: FY2026.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026MaterialisedAnnual report
「19 May 2025–31 March 2026 4,400 shares Increase resulting from the exercise of stock acquisition rights.」
During the current period, 4,400 shares were issued through the exercise of stock acquisition rights. The equivalent of 26,000 shares under the fourth series and 70,000 shares under the fifth series remain unexercised. - 2026-05-13MaterialisedRevision of earnings forecasts
「Proceeds from the issuance of shares through the exercise of stock acquisition rights 2,664」
The issuance of shares through the exercise of stock acquisition rights also occurred during the fiscal year. - FY2026-H1MaterialisedAnnual report
「1 April 2025–30 September 2025 3,000 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the interim period, 3,000 shares were issued through the exercise of stock acquisition rights, meaning that part of the potential dilution is progressing as actual share issuance. 26,000 units of the fourth series of stock acquisition rights and the equivalent of 76,000 common shares under the fifth series remain outstanding. - FY2025-H1MaterialisedAnnual report
「1 April 2024–30 September 2024 5,600 (Note 1) Increase resulting from the exercise of stock acquisition rights.」
During the interim period, 5,600 shares were issued through the exercise of stock acquisition rights. In addition, the number of shares remaining under the fifth series of stock acquisition rights declined from 92,000 to 76,000, meaning that part of the potential dilution is progressing as actual share issuance. - FY2024MaterialisedAnnual report
「Increase from the issuance of new shares through the exercise of stock acquisition rights 51,000 shares Fifth series of stock options Number of stock options by class of shares Common stock 92,000 shares」
During the current period, 51,000 shares were issued through the exercise of stock acquisition rights, resulting in actual dilution. In addition, 92,000 shares under the fifth series of stock acquisition rights remain outstanding. - FY2024-Q3MaterialisedAnnual report
「1 October 2023–31 December 2023 1,000 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter, 1,000 shares were issued through the exercise of stock acquisition rights, meaning that part of the potential dilution materialised as an actual share issuance. - FY2024-Q2MaterialisedAnnual report
「1 August 2023–30 September 2023 2,000 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter, 2,000 shares were issued through the exercise of stock acquisition rights, meaning that part of the potential dilution materialised as an actual share issuance. - FY2024-Q1WorsenedAnnual report
「If all of these stock acquisition rights are exercised, the total number of common shares issued by the company will increase by 92,000, resulting in maximum dilution of 1.4%.」
The resolution to issue the fifth series of stock acquisition rights added new potential dilution of up to 92,000 shares, or 1.4%. Meanwhile, 2,800 shares were issued through the exercise of stock acquisition rights during the first quarter. - FY2023MitigatedAnnual report
「As of 31 May 2023, the number of potential shares represented by these stock options was 178,600, equivalent to 3.9% of the 4,623,000 issued shares.」
While the potential share ratio declined from 5.7% to 3.9%, the potential for dilution from the exercise of stock acquisition rights remains. - FY2023-Q2MaterialisedAnnual report
「1 July 2022–30 September 2022 5,000 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter, 5,000 shares were issued through the exercise of stock acquisition rights, meaning that part of the potential dilution materialised as an actual share issuance. - FY2023-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
During the first quarter, 400 shares were issued through the exercise of stock acquisition rights, meaning that part of the potential dilution from stock option exercises materialised as an actual share issuance. - FY2022MitigatedAnnual report
「As of 31 May 2022, the number of potential shares represented by these stock options was 263,000, equivalent to 5.7% of the 4,580,800 issued shares.」
While the ratio of potential shares declined from the previously disclosed 279,800 shares, or 6.1%, to 5.7%, the potential for dilution from the exercise of stock acquisition rights remains. - FY2022-Q2WorsenedAnnual report
「At a meeting of the Board of Directors held on 9 September 2021, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights to its directors, employees and external collaborators, and issued them on 30 September 2021. Number of stock acquisition rights (units)* 40,000」
The company newly issued 40,000 stock acquisition rights, adding potential dilution exposure. - FY2021First statedAnnual report
「As of the date of submission of this document, the number of potential shares represented by these stock options was 279,800, equivalent to 6.1% of the 4,560,000 issued shares.」
The company disclosed potential dilution equivalent to 6.1% from the future exercise of stock options.